Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

39. Background on drinking water standards in the Safe Drinking Water Act (SDWA). US Environmental Protection Agency. www.epa.gov/dwstandardsregulations/ background-drinking-water-standards-safe-drinking-water-act-sdwa. Updated February 8, 2017. Accessed March 30, 2019.

40. Там же.

41. Perlman H. Contamination in U.S. private wells. US Geological Survey. http://water.usgs.gov/edu/gw-well-contamination.html. Updated December 2, 2016. Accessed March 30, 2019.

42. Trichloroethylene (TCE) contamination in public water systems nationwide: 2015. Environmental Working Group. www.ewg.org/ interactive-maps/2018-tce. Accessed March 30, 2019.

43. Protect your home’s water. US Environmental Protection Agency. www.epa.gov/ privatewells/protect-your-homes-water#welltestanchor. Updated December 15, 2017. Accessed March 29, 2019.

44. Sharp R, Pestano JP. Water treatment contaminants. Environmental Working Group. February 27, 2013. www.ewg.org/research/watertreatment-contaminants. Accessed March 30, 2019.

45. Choosing home water filters and other water treatment systems. Centers for Disease Control and Prevention. www.cdc.gov/healthywater/ drinking/home-water-treatment/water-filters/step2.html. Updated June 3, 2014. Accessed March 30, 2019.

46. Там же.

47. Patient groups applaud spending bill that funds important neuro data system. National Multiple Sclerosis Society. September 28, 2018. www. nationalmssociety.org/About-the-Society/News/Patient-Groups-Applaud-Spending-Bill-That-Funds-Im. Accessed January 4, 2019.

48. Farmers, ranchers, and other agricultural managers. US Bureau of Labor Statistics. Occupational Outlook Handbook. www.bls.gov/ooh/management/farmers-ranchers-and-other-agricultural-managers.htm. Accessed March 30, 2019.

49. Damalas CA, Koutroubas SD. Farmers’ exposure to pesticides: toxicity types and ways of prevention. Toxics 2016;4(1):1.

50. Там же.

51. Там же.

52. Pesticide information profile: paraquat. Extension Toxicology Network. September 1993. http://pmep.cce.cornell.edu/profiles/extoxnet/metiram-propoxur/paraquat-ext.html. Accessed March 25, 2019.

53. Furlong M, Tanner CM, Goldman SM, et al. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson’s disease. Environment International. 2015;75:144–150.

54. Там же.; Damalas CA, Koutroubas SD. Farmers’ exposure to pesticides: toxicity types and ways of prevention. Toxics 2016;4(1):1.

55. Pezzoli G, Cereda E. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology. 2013;80(22):2035–2041; Goldman SM, Quinlan PJ, Ross GW, et al. Solvent exposures and Parkinson disease risk in twins. Annals of Neurology. 2012;71(6):776–784; Bale AS, Barone S, Scott CS, Cooper GS. A review of potential neurotoxic mechanisms among three chlorinated organic solvents. Toxicology and Applied Pharmacology. 2011;255(1):113–126.

56. Trichloroethylene. US Environmental Protection Agency. April 1992. www.epa.gov/sites/ production/files/2016-09/documents/ trichloroethylene.pdf. Updated January 2000. Published 1992. Accessed March 28, 2019; Risk management for trichloroethylene (TCE). US Environmental Protection Agency. www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-management-trichloroethylene-tce. Updated December 14, 2017. Accessed November 16, 2018.

57. Trichloroethylene toxicity: where is trichloroethylene found? Agency for Toxic Substances & Disease Registry. November 8, 2007. www.atsdr. cdc.gov/csem/csem.asp?csem=15&po=5. Accessed March 30, 2019.

58. Trichloroethylene. National Toxicology Program. November 2016. www. niehs.nih.gov/ health/materials/tce_508.pdf; OSH answers fact sheets: trichloroethylene. Canadian Centre for Occupational Health and Safety. www.ccohs.ca/oshanswers/chemicals/chem_profiles/ trichloroethylene. html. Updated January 3, 2017. Accessed March 30, 2019.

59. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism. Neurology. 2001;56(1):8; Sadek AH, Rauch R, Schulz PE. Parkinsonism due to manganism in a welder. International Journal of Toxicology. 2003;22(5):393–401; Flynn MR, Susi P. Neurological risks associated with manganese exposure from welding operations – a literature review. International Journal of Hygiene and Environmental Health. 2009;212(5):459–469.

60. Welders, cutters, solderers, and brazers. US Bureau of Labor Statistics. Occupational Outlook Handbook. www.bls.gov/ooh/production/ welders-cutters-solderers-and-brazers.htm. Accessed March 30, 2019.

61. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine. 2013;368(14):1279–1290; Singh RB, Dubnov G, Niaz MA, et al. Effect of an indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised singleblind trial. The Lancet. 2002;360(9344):1455–1461.

62. Ascherio A, Zhang SM, Hernan MA, et al. Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women. Annals of Neurology. 2001;50(1):56–63; Ross GW, Abbott RD, Petrovitch H, et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000;283(20):2674–2679.

63. Haspel T. The truth about organic produce and pesticides. Daily Gazette. May 23, 2018.

64. Blackwell DL, Clarke TC. State variation in meeting the 2008 federal guidelines for both aerobic and muscle-strengthening activities through leisure-time physical activity among adults aged 18–64: United States, 2010–2015. National Health Statistics Report. 2018;Jun(112):1-22.

65. Schenkman M, Moore CG, Kohrt WM, et al. Effect of highintensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurology . 2018;75(2):219–226; Miller Koop M, Rosenfeldt AB, Alberts JL. Mobility improves after high intensity aerobic exercise in individuals with Parkinson’s disease. Journal of the Neurological Sciences . 2019;399:187–193.

66. Snijders AH, van Kesteren M, Bloem BR. Cycling is less affected than walking in freezers of gait. Journal of Neurology, Neurosurgery & Psychiatry. 2012;83(5):575–576.

67. Hootman JM, Dick R, Agel J. Epidemiology of collegiate injuries for 15 sports: summary and recommendations for injury prevention initiatives. Journal of Athletic Training . 2007;42(2):311–319.

68. Gates RM. Duty: Memoirs of a Secretary at War. Rpt. ed: Vintage; 2015.

69. National Center for Injury Prevention and Control. Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem. Centers for Disease Control and Prevention; September 2003; National Center for Injury Prevention and Control. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation . Centers for Disease Control and Prevention; 2015; The CDC, NIH, DoD, and VA Leadership Panel. Report to Congress on Traumatic Brain Injury in the United States: Understanding the Public Health Problem among Current and Former Military Personnel. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Department of Defense (DoD), and the Department of Veterans Affairs (VA); 2013.

70. McCrea M. Mild Traumatic Brain Injury and Postconcussion Syndrome: The New Evidence for Diagnosis and Treatment. Oxford University Press; 2008; Mac Donald CL, Johnson AM, Cooper D, et al. Detection of blastrelated traumatic brain injury in U.S. military personnel. New England Journal of Medicine. 2011;364(22):2091–2100; Levin HS, Diaz-Arrastia RR. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurology. 2015;14(5):506–517; Andrews PJD, Sinclair HL, Rodriguez A, et al. Hypothermia for intracranial hypertension after traumatic brain injury. New England Journal of Medicine . 2015;373(25):2403–2412.

71. Maas AIR, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurology. 2017;16(12):987-1048.

72. Mission and goals. National Institutes of Health. www.nih.gov/about-nih/what-we-do/mission-goals. Updated July 27, 2017. Accessed March 30, 2019.

73. Marar M, McIlvain NM, Fields SK, Comstock RD. Epidemiology of concussions among United States high school athletes in 20 sports. American Journal of Sports Medicine. 2012;40(4):747–755; Lincoln AE, Caswell SV, Almquist JL, Dunn RE, Norris JB, Hinton RY. Trends in concussion incidence in high school sports: a prospective 11-year study. American Journal of Sports Medicine . 2011;39(5):958–963; Hootman JM, Dick R, Agel J. Epidemiology of collegiate injuries for 15 sports: summary and recommendations for injury prevention initiatives. Journal of Athletic Training . 2007;42(2):311–319.

74. Moses H, Matheson DM, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA . 2015;313(2):174–189.

75. Accelerating Medicines Partnership (AMP): Parkinson’s disease. US Department of Health & Human Services. www.nih.gov/research-training/accelerating-medicines-partnership-amp/parkinsons-disease. Updated October 26, 2018. Accessed February 8, 2019.

76. Alzheimer’s and dementia: facts and figures. Alzheimer’s Association. www.alz.org/alzheimers-dementia/facts-figures. Accessed February 8, 2019.

77. Pfizer ends research for new Alzheimer’s, Parkinson’s drugs. Reuters. January 7, 2018. www.reuters.com/article/us-pfizer-alzheimers/pfizer-ends-research-for-new-alzheimers-parkinsons-drugs-idUSKBN1EW0TN. Accessed January 4, 2019.

78. Dunn A. Pfizer, Bain Capital launch neuroscience company backed with $350M. BioPharma Dive. October 23, 2018. www.biopharmadive. com/news/pfizer-bain-capital-neuroscience-Cerevel/540359. Accessed February 8, 2019.

79. Moses H, Matheson DM, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174–189.

80. American Parkinson Disease Association. www.apdaparkinson.org/ about-apda. Accessed March 30, 2019.

81. Brian Grant Foundation. https://briangrant.org. Accessed March 30, 2019.

82. Parkinsons Foundation 2017 Annual Report. Parkinson’s Foundation; 2017.

83. Impact of the Ice Bucket Challenge. ALS Association. www.alsa.org/ fight-als/ibc-infographic.html. Accessed February 8, 2019.

84. ACT UP New York. www.actupny.org. Accessed March 30, 2019.

85. ParkinsonNet. www.parkinsonnet.info. Accessed January 5, 2019.

86. Okun MS, Ramirez-Zamora A, Foote KD. Neuromedicine service and science hub model. JAMA Neurology. 2018;75(3):271–272.

87. Bloem BR, Rompen L, de Vries NM, Klink A, Munneke M, Jeurissen P. ParkinsonNet: a low-cost health care innovation with a systems approach from the Netherlands. Health Affairs. 2017;36:1987–1996.

88. van der Kolk NM, de Vries NM, Penko AL, et al. A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson’s disease: results of a small randomised feasibility trial. Journal of Neurology, Neurosurgery & Psychiatry . 2018;89(9):1003.

89. Szanton SL, Leff B, Wolff JL, Roberts L, Gitlin LN. Home-based care program reduces disability and promotes aging in place. Health Affairs . 2016;35(9):1558–1563.